Nestle is debuting a new infant formula containing a proprietary blend in Hong Kong in November 2023. The blend is said to be an “all-round” nutrition for supporting multiple growth areas, including digestive, bone, and cognitive health.
FrieslandCampina said its 2’-fucosyllactose trademarked Aequival has been approved by Australia’s and New Zealand’s authorities for use in infant milk formula, and that it is on track in expanding its human milk oligosaccharide (HMO) portfolio.
